8 completed, 2 active not recruiting, 2 recruiting. 5 Not applicable, 3 Phase 1, 2 Phase 2, 1 Early Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 3, Active not recruiting 2 |
| Phase 1 | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Crossing Over, Genetic: new trials by email Literature Review of Crossing Over, Genetic trials Research Report on Crossing Over, Genetic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager Target trough IgG level of 8-10 g/L, Target trough IgG level 4-6 g/L, No history of recurrent or severe infections and total IgG level higher or equal at 4 g/L - Multiple Myeloma Refractory, Relapsed Multiple Myeloma | Phase 4 | Recruiting | CHU de Quebec-Universite Laval | 80 | 2026-01-05 | 2026-07-22 |
| In Vivo Evaluation of Anti-inflammatory and Antithrombotic Health Promoting Properties of Extra Virgin Olive Oil Versus Classic Table Olive Oil in Healthy Subjects Olive Oil 1, Olive oil (placebo) 1, Olive Oil 2 - Antiplatelet, Antithrombotic | Not applicable | Active not recruiting | Democritus University of Thrace | 54 | 2025-11-01 | 2026-08-25 |
| Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide 177Lu-DOTA-JR11 (Phase 0); Cycle 1 and Cycle 2 (cross-over), 177Lu-DOTATOC (Phase 0); Cycle 1 and Cycle 2 (cross-over), Cycle 3 and 4, 177Lu-DOTA-JR11 (Phase I/II) - Meningioma | Phase 1 / Phase 2 | Recruiting | University Hospital, Basel, Switzerland | 18 | 2021-04-21 | 2025-04-13 |
| Staccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's Disease 009-A1, 009-A2, 009-A3 - Parkinson's Disease | Phase 1 | Completed | Alexza Pharmaceuticals, Inc. | 35 | 2019-10-16 | 2020-11-04 |
| Comparison of Plant and Animal Proteins on Amino Acid Concentrations Animal Proteins (crossover), Plant-based protein blends type 1 (crossover), Plant-based protein blends type 2 (crossover) - Healthy Resistance-Trained Males | Not applicable | Completed | Danone North America | 20 | 2018-09-20 | 2018-11-26 |
| Randomized Controlled Trial on Colorectal Cancer Screening Among Quality Circles of Primary Care Physicians Multilevel training intervention (intervention group), Multilevel training intervention (control group with crossover) - Colorectal Cancer | Not applicable | Completed | University of Bern | 44 | 2018-03-14 | 2026-02-27 |
| The NORDSTEN Studies/ The Spinal Stenosis Study Bilateral laminotomy (BL), Unilateral laminotomy with crossover (UL), Spinous Process Osteotomy (SPO) - Lumbar Spinal Stenosis | Not applicable | Active not recruiting | Haukeland University Hospital | 465 | 2013-11-01 | 2020-08-12 |
| Comparing Site Specific Mouth Disinfection With Commercial Oral Mouth Rinse With Traditional Oral Maouth Disinfection traditional mouth rinsing and site-specific mouth rinsing (crossover) - Oral Odor (Halitosis), The Study Want to Know if Site Specific Mouth Rinsing With Oral Mouth Disinfectants Can be Better Than Paonoral Mouth Rinsing | Early Phase 1 | Completed | Al-Baha University | 20 | 2013-07-01 | 2014-08-20 |
| Crossover Versus Stabilometric Platform in Parkinson's Disease Crossover, Stabilometric Platform - Parkinson's Disease | Completed | Ospedale Generale Di Zona Moriggia-Pelascini | 60 | 2013-06-01 | 2014-03-28 | |
| H-22411: BOTOX® for Peyronie's Disease 100 units of Botulinum Toxin Type A, Preservative free normal saline, 100 units Botulinum Toxin A - Peyronie's Disease | Phase 2 | Completed | Mohit Khera | 12 | 2009-08-07 | 2024-04-08 |
| An Active Approach to Treat Amblyopia: Video Game Play Perceptual learning, Video Game, Crossover (Occlusion therapy + Video Game) - Amblyopia | Not applicable | Completed | University of California, Berkeley | 20 | 2004-12-01 | 2016-05-17 |
| Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF) Intramyocardial Injection of stem cells via NOGA Mapping, Control, then Stem Cell Therapy - Ischemic Cardiomyopathy | Phase 1 | Completed | Texas Heart Institute | 30 | 2004-04-01 | 2016-11-28 |
Parkinson Disease (2) · Amblyopia (1) · Colorectal Neoplasms (1) · Halitosis (1) · Meningioma (1) · Multiple Myeloma (1) · Neoplasms (1) · Penile Induration (1) · Spinal Stenosis (1)
Al-Baha University (1) · Alexza Pharmaceuticals, Inc. (1) · CHU de Quebec-Universite Laval (1) · Danone North America (1) · Democritus University of Thrace (1) · Haukeland University Hospital (1) · Mohit Khera (1) · Ospedale Generale Di Zona Moriggia-Pelascini (1) · Texas Heart Institute (1) · University Hospital, Basel, Switzerland (1) · University of Bern (1) · University of California, Berkeley (1)
United States (3) · Canada (2) · Switzerland (2) · Greece (1) · Italy (1) · Netherlands (1) · Norway (1)
Alexandros Tsoupras (1) · Dennis M Levi, OD, PhD (1) · Dominik Cordier, PD Dr. med. (1) · Dr Vincent Laroche, MD,FRCPC (1) · Emerson Perin, MD,PhD. (1) · Geert J Groeneveld, MD, PhD (1) · Giuseppe Frazzitta, MD (1) · Kari Indrekvam Indrekvam, MD, Dr Med (1) · Mohit Khera, MD, MBA (1) · Reto Auer, MD, MAS (1) · Roger W Li, OD, PhD (1)
PMID 18824189, PMID 19008199, PMID 19109504, PMID 19250947, PMID 21641354, PMID 21912514, PMID 22558234, PMID 25715870, PMID 26909178, PMID 28327114, PMID 32556585, PMID 34797405, PMID 35033042, PMID 35344046, PMID 37395780, PMID 37407851, PMID 38423782, PMID 39134699, PMID 42245438
2019 (1), R01EY001728 (1)